Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Bayer Says Legal Woes Could Force It To Pull Weedkiller

German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

International Business Times

Gilead Dives As Its Biggest Moneymaker Misses. Here's Why It Could Still Be A 'Safe Haven' Stock.

Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell early Friday.

Investors Business Daily

Will This Cancer Stock Buck Trump's Tariff Onslaught As It Nears Buy Point, Earnings?

BeiGene stock has formed an early-stage base with a buy point of 287.88 ahead of its first-quarter results on May 7.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

US drug firm Merck says existing Trump tariffs will cost it $200m this year

Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports

The Guardian - UK

Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, Gardasil.

Investors Business Daily

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investors Business Daily

Stroke Management Drug Firm Climbs To Key Level Ahead Of Earnings; But Beware This Pharma Tariff

Penumbra stock is holding the 50-day moving average in a base ahead of earnings on Wednesday.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

The Guardian - UK

Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

Investors Business Daily

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours

The Independent UK

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

The Guardian - UK

Leadership Through Kelli Rodriguez's Lens: Diversity, Communication, & Women's Empowerment

For more than 20 years, Rodriguez has played an instrumental role in launching, restructuring, and scaling global and domestic brands, cementing her reputation as an industry leader.

International Business Times

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

International Business Times

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug

Argenx stock jumped Friday after the FDA cleared its autoimmune disease drug, Vyvgart Hytrulo, for at-home treatment.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Latin Times

Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump

Novartis plans a $23 billion U.S. expansion to boost drug production and counter potential import tariffs.

Investors Business Daily

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

Ani Pharmaceuticals stock is near a buy point in a cup-with-handle base after flashing a "golden cross" signal.

Investors Business Daily

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.

Investors Business Daily

This Medical Supplies Distributor Dodges A Tariff Bullet

This medical supplies distributor stock is off a recent high and back in a buy zone.

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce tariffs on the industry soon.

The Guardian - UK

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

The Guardian - UK

China, America and pay inject drama into AstraZeneca’s AGM

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The Guardian - UK

Painkillers without the addiction? The new wave of non-opioid pain relief

Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

Investors Business Daily

Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-Off

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Investors Business Daily

Biotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe.

Investors Business Daily

IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche

TG Therapeutics rallied Wednesday after Roche's rival multiple sclerosis treatment, Ocrevus, missed its mark in a study.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

771 stories

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.